Mallinckrodt plc, a leading pharmaceutical company, today marked the donation of £100,000 to Ashford and St. Peter’s Hospitals NHS Foundation Trust at St Peter’s Hospital in Chertsey.
Aileen McLeish, Chairman of Ashford and St. Peter’s Hospitals NHS Foundation Trust thanked Mallinckrodt for the donation, which will help support the important work undertaken by the Trust’s Neonatal Intensive Care Unit.
“On behalf of the Trust, I would like to thank Mallinckrodt for their extremely generous donation and for their interest in Ashford and St Peter’s Hospitals. We are always keen to forge positive links with the local business community and look forward to developing our relationship with Mallinckrodt further in the future.”
Mark Trudeau, President and Chief Executive Officer of Mallinckrodt, remarked: “This donation demonstrates our commitment to supporting local healthcare providers and the important work they do with the patient community, a community of which we are proud to be a part.” Mallinckrodt recently opened its Global Corporate headquarters in nearby Staines-upon-Thames.
After the ceremony, Dr. Paul Crawshaw, Divisional Director for Women and Children’s Services and Consultant Neonatologist showed Mr. Trudeau around the Neonatal Intensive Care Unit at St. Peter’s Hospital. He explained how the donation will help support the Unit’s vital work in particular with specialist training for nursing staff in areas such as pathophysiology, pharmacology, advanced medicines management and life support.
Pictured above: From LtoR: Dr Paul Crawshaw Consultant Neonatologist; Meredith Fisher Chief Public Affairs Officer, Mallinckrodt; Mark Trudeau President & Chief Executive Officer, Mallinckrodt; Aileen McLeish Trust Chairman, Mark Tyndall VP Government Affairs, Mallinckrodt; Louise McKenzie Trust Director of Workforce Transformation; Sara Robertson Matron on the Neonatal Intensive Care Unit.